Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
The blood–brain barrier (BBB) is a barrier that separates the blood from the brain tissue and possesses unique characteristics that make the delivery of drugs to the brain a great challenge. To achieve this purpose, it is necessary to design strategies to allow BBB passage, in order to reach the bra...
Saved in:
Main Authors: | Rúben G. R. Pinheiro, Ana Joyce Coutinho, Marina Pinheiro, Ana Rute Neves |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f8f503332d9e40ada4177774d6bea6d7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liposome based drug delivery as a potential treatment option for Alzheimer’s disease
by: Carely Hernandez, et al.
Published: (2022) -
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
by: Claudia Riccardi, et al.
Published: (2021) -
Topical Insights Into the Post-Approval Controversies of Aducanumab
by: Dhiraj Kumar, et al.
Published: (2021) -
Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease
by: Peilin Sun, et al.
Published: (2021) -
Drug delivery
Published: (1993)